|Year : 2017 | Volume
| Issue : 1 | Page : 71-75
Experience with the quantitative lytA gene real-time polymerase chain reaction for the detection of Streptococcus pneumoniae from pediatric whole blood in Pakistan
Furqan Kabir1, Sahrish Muneer1, Adil Kalam1, Ana Sami1, Shahida Qureshi1, Aneeta Hotwani1, Atif Riaz1, Syed Mohiuddin1, Mohammad Tahir Yousafzai1, Sara Hussain1, Asad Ali1, Sadia Shakoor2
1 Department of Paediatrics and Child Health, Aga Khan University, Karachi, Pakistan
2 Department of Paediatrics and Child Health; Department of Pathology and Laboratory Medicine, Aga Khan University, Karachi, Pakistan
|Date of Web Publication||24-Jul-2017|
Department of Paediatrics and Child Health and Pathology, Laboratory Medicine, Aga Khan University, P.O. Box 3500, Stadium Road, Karachi
Source of Support: None, Conflict of Interest: None
Background: We present our experience with optimization and diagnostic use of quantitative real-time polymerase chain reaction (PCR) targeting the lytA gene of Streptococcus pneumoniae for the detection of S. pneumoniae in whole blood of children <5 years of age. The assay was optimized to detect ≥5 CFU/10 μl or 1 copy of DNA/2 μl of blood. Methods: This assay was applied on 1912 whole blood specimens collected from children <5 years of age with pneumonia, of which 35 specimens were lytA positive. The bacterial loads were determined through categorization of load into five different categories, i.e., very high load, high load, moderate load, low load, and very low load. Results: Of the 35 lytA-positive samples, 9 (25.71%), 4 (11.42%), 1 (2.85%), 13 (37.14%), and 8 (22.85%) were categorized as very high load, high load, moderate load, low load, and very low load, respectively. Extracted samples were also subjected to serotyping by the Centers for Disease Control and Prevention PCR scheme. Positive samples with very high load and high load category were serotyped successfully in all instances. A high proportion of samples with low and very low load (61.53% and 75%, respectively) remained untypeable by the currently proposed schemes. Conclusions: LytA PCR assay in whole blood provides rapid and sensitive results for the diagnosis of invasive S. pneumoniae disease in a resource-limited setting, while also being amenable to quantitation and serotyping.
Keywords: Blood, immunochromatography, lytA gene, real-time polymerase chain reaction, serotyping, S. pneumoniae
|How to cite this article:|
Kabir F, Muneer S, Kalam A, Sami A, Qureshi S, Hotwani A, Riaz A, Mohiuddin S, Yousafzai MT, Hussain S, Ali A, Shakoor S. Experience with the quantitative lytA gene real-time polymerase chain reaction for the detection of Streptococcus pneumoniae from pediatric whole blood in Pakistan. Biomed Biotechnol Res J 2017;1:71-5
|How to cite this URL:|
Kabir F, Muneer S, Kalam A, Sami A, Qureshi S, Hotwani A, Riaz A, Mohiuddin S, Yousafzai MT, Hussain S, Ali A, Shakoor S. Experience with the quantitative lytA gene real-time polymerase chain reaction for the detection of Streptococcus pneumoniae from pediatric whole blood in Pakistan. Biomed Biotechnol Res J [serial online] 2017 [cited 2019 Jul 22];1:71-5. Available from: http://www.bmbtrj.org/text.asp?2017/1/1/71/211409
| Introduction|| |
Streptococcus pneumoniae is a major cause of childhood morbidity and mortality globally. Invasive pneumococcal disease (IPD) and pneumococcal pneumonia in children are now considered preventable illnesses following the introduction of pneumococcal conjugate vaccines (PCVs), but reduction in the rates of IPD incidences highly depends on vaccine serotype proportions causing disease.
Laboratory diagnosis of IPD by conventional culture and serological methods has several limitations including but not limited to low sensitivity due to prior antibiotic use and fastidiousness of the organism, longer turnaround time (TAT), and requirement of larger volumes of blood. Hence, improved molecular diagnostic methods (e.g., polymerase chain reaction [PCR]) of targeting the S. pneumoniae virulence genes (psaA, ply, pbp, lytA) have been increasingly used.,,,, More recently, probe-based real-time PCR has been developed with rapid TAT, increased sensitivity, and multiplexing capability., lytA gene has shown greater utility and increased sensitivity., However, the detection of S. pneumoniae in blood through real-time PCR has its own limitations such as presence of inhibitors in blood and potential cross-reactivity (Streptococcus mitis is known to harbor low quantities of lytA and ply genes) as reported by several authors.,,,, Owing to limitations described in literature, this assay has not been widely adopted for routine use in the diagnosis of IPD.
We optimized a quantitative lytA gene real-time PCR in whole blood and applied it to a large number of whole blood samples from children with pneumonia in a low-resource setting where routine diagnosis through blood cultures is not possible. We also assessed the impact of this assay on serotyping of S. pneumoniae. Our secondary aim was to compare this quantitative lytA gene real-time PCR with a rapid immunochromatography testing (ICT-BINAXNOW®) that we conducted on a subset of samples.
| Methods|| |
Generation of standard curve and lytA assay optimizations
Standard curve was generated by setting up 10-fold serial dilutions of S. pneumoniae ATCC 49619 and suspending in healthy donor's ethylenediaminetetraacetic acid (EDTA) blood to achieve final concentrations of 5 × 106–5 × 102 CFUs/mL. In brief, serial dilutions of S. pneumoniae ATCC 49619 0.5 McFarland (McF) suspension were prepared in 3 ml of phosphate-buffered saline. 190 μl of EDTA blood was spiked with 10 μl of each dilution. To verify assay specificity, blood was also spiked with 0.5 McF suspensions of S. viridans with a 5 × 106 CFU/ml. DNA was extracted and followed by lytA real-time PCR, as described below [Supplementary Table 1 [Additional file 1]]. Standard curve was generated by plotting the CFU/mL concentrations against the cycle threshold (Ct) values of spiked samples.
The optimization and routine use were carried out as part of the pneumococcal conjugate vaccine impact study, which is being conducted in five districts of Sindh province in Pakistan. The study was approved by the Aga Khan University Ethical Review Committee (ERC no. 2818-PED-ERC-13). Whole blood samples (n = 1912) from children aged <5 years with pneumonia, meeting the WHO criteria, were collected, after obtaining written informed consent from parents or guardians of children. Two milliliters of blood was collected in EDTA tubes. lytA PCR was performed for the identification of S. pneumoniae as described below. Blood specimens that were positive for S. pneumoniae lytA gene were further serotyped by sequential multiplex conventional or real-time PCR. A subset (n = 1271) of blood specimens were also tested with pneumococcal ICT-BINAXNOW® testing, as per manufacturer's instructions for urine samples.
DNA extraction from whole blood
Prelysis of blood samples was carried out by treating 200 μl of well-mixed whole blood with 3 μl of 2500U/ml mutanolysin, 20 μl lysozyme (200 mg/ml), 13.5 μl lysostaphin (1.5 mg/ml), and 65 μl TE buffer (pH 8), incubating at 37°C for 30 min, followed by the DNA extraction using QIAamp DNA Blood Mini kit (QIAGEN Inc., Valencia, California, USA.) according to manufacturer's instructions (spin protocol). DNA was archived at −20°C, until further processing.
Real-time monoplex lytA polymerase chain reaction for the identification of Streptococcus pneumoniae in blood
Real-time monoplex lytA PCR was carried out by targeting lytA gene, as described by Carvalho Mda et al. in 2007. In brief, a 25 μl PCR reaction mixture was prepared by adding 12.5 μl of TaqMan® Universal PCR Master Mix (Applied Biosystems®, Life Technologies, USA), 1 μl of each forward and reverse lytA primer (10 μM), 0.15 μl of lytA probe (5 μM), 6.35 μl of molecular biology grade nuclease-free water, and finally, 2 μl of template DNA added to the mixture. Thermal cycling was performed, using cycling conditions: 50°C for 2 min, 95°C for 10 min, followed by 50 cycles at 95°C for 15 s and 60°C for 1 min, reaction was set up in Corbett Rotor-Gene 6000 thermal-cycler (Corbett Life Science, USA). A Ct cutoff ≤35 was set for positive specimens. The assay was optimized to detect 500 CFU/ml of S. pneumoniae in 200 μL of whole blood, based on standard curve data.
RNAse P gene monoplex real-time polymerase chain reaction assay used as internal positive control reaction
RNAse P gene monoplex real-time PCR was performed independently on every specimen as an internal positive control reaction, to rule out the presence of any inhibitors and false negativity.
Pneumococcal serotyping by sequential multiplex conventional/real-time polymerase chain reaction
S. pneumoniae s erotyping of those blood samples with lytA Ct value ≥30 was performed by triplex sequential real-time PCR as described by Pimenta et al. In brief, 21 primer pairs were grouped into seven triplex reactions for covering 37 serogroups/serotypes. PCR was carried out in reaction mixture volumes of 25 μl, using Invitrogen-Platinum Quantitative PCR SuperMix-UDG kit (Invitrogen, USA), with 10 μM primers and probes. Amplification was performed on Applied Biosystems® 7500 real-time PCR system (Applied Biosystems®, Life Technologies, USA).
Blood specimens with lytA Ct value ≤30 were subjected to conventional multiplex PCR serotyping as previously carried out by Pai et al. In brief, eight multiplex PCR reactions, including 39 primer pairs to cover 68 serogroups/serotypes were performed. The primer for the conserved pneumococcal polysaccharide capsule gene (cpsA) was added as control with each multiplex reaction. PCR was carried out in reaction mixture volumes of 25 μl with 25 μM primers and 2X multiplex Master Mix (Qiagen Cat# 206145, Germany). Amplification was performed in Eppendorf Master Cycler (Eppendorf, Hamburg, Germany). PCR products were electrophoresed on to 2% agarose gel stained with SYBR® Green (Sigma, USA) and visualized under ultraviolet light (GEL-DOC Biorad Inc., USA).
A subset of blood specimens (n = 1271) were also subjected to ICT-BINAXNOW® S. pneumoniae kit testing (Alere, Hague, the Netherlands) as per manufacturer's instructions for urine samples. In brief, a swab was dipped into a whole sample and then inserted into the test device. Three drops of reagent-A solution were added and results were recorded after 15 min. The test was interpreted as positive if both sample and control lines were present, while interpreted as negative if only the control line was present.
| Results|| |
Standard curve data
Standard curve showed a linear relationship between Ct values and CFU/ml, DNA copies/2 μl of the sample [Figure 1]. The limit of detection for the assay was 5 CFU/10 μl, equivalent to 1 copy of DNA/2 μl of the sample. The analytical sensitivity of the assay was found to be 500 CFU/ml of S. pneumoniae in 200 μl of blood. Blood samples spiked with S. viridans were negative for lytA quantitative real-time PCR, showing no cross-reactivity [Supplementary Table 1].
|Figure 1: Line graph showing the comparison of cycle threshold values in quantitative lytA real-time polymerase chain reaction on Y-axis and CFU/ml (in the upper image) or DNA copies/2 μl (in the lower image) on X-axis. Trend line showing a linear relationship between the cycle threshold values and CFU/ml or DNA copies/2 μl TAC. Depicting a linear relationship of cycle threshold values versus CFU/ml, DNA copies/2 μl on a standard curve. CFU/ml: colonies forming unit/milliliter, DNA copies/μl: deoxyribonucleic acid/microliter|
Click here to view
Result interpretation and quality control
A clinical whole blood specimen was considered positive for S. pneumoniae when lytA PCR yielded a Ct value ≤35, and the internal control human RNASeP gene was positive at a Ct value of ≤35. PCR-negative control and extraction-negative control yielded no Ct value and remained negative.
lytA quantitative real-time polymerase chain reaction assay results
A total of 1912 blood specimens were subjected to lytA quantitative real-time PCR results, of which 35 specimens (1.83%) were found positive. On the basis of standard curve data, five categories with respect to bacterial load were made, i.e., very high load (i.e., >5 × 106 CFU/ml), high load (between 5 × 105 and 5 × 106 CFU/ml), moderate load (between 5 × 104 and 5 × 105 CFU/ml), low load (between 5 × 103 and 5 × 104 CFU/ml), and very low load (between 5 × 102 and 5 × 103 CFU/ml). Of the 35 lytA positives, 9 (25.71%), 4 (11.42%), 1 (2.85%), 13 (37.14%), and 8 (22.85%) were categorized as very high load, high load, moderate load, low load, and very low load, respectively.
Correlation with serotyping results and Immunochromatography-BINAXNOW®
[Table 1] shows the correlation between lytA real-time PCR quantification with pneumococcal serotypes and ICT-BINAXNOW®.
|Table 1: Relationship of quantitative lytA real-time polymerase chain reaction with immunochromatography-BINAXNOW® and pneumococcal serotyping|
Click here to view
All specimens with either very high load or high load were successfully serotyped. However, a large proportion of the samples with low load to very low load remained untypeable by the serotypes included in the schemes. One outlier in the moderate load category also remained untypeable.
The overall percentage agreement between ICT-BINAXNOW® and quantitative lytA real-time PCR was found to be 98.74%, while positive percentage agreement and negative percentage agreement were 48.38% and 100%, respectively [Supplementary Table 2 [Additional file 2]]. The lowest detectable limit for a positive ICT-BINAXNOW® was determined to be between 5 × 102 and 5 × 103 CFU/ml.
| Discussion|| |
Advancement in nucleic acid detection techniques, particularly probe-based real-time PCR, offers an opportunity to improve the diagnosis of invasive S. pneumoniae disease. Detection of S. pneumoniae is difficult, because it is fastidious, difficult to grow due to autolysis phenomenon, and there is a limited experience and literature available for a real-time PCR diagnosis of IPD in resource-limited settings. We have successfully demonstrated quantitative lytA real-time PCR as well as ICT-BINAXNOW® in a cohort of children <5 years of age with pneumonia. Although lytA real-time PCR does not replace conventional diagnosis, it offers rapid detection of S. pneumoniae in blood and also provides valuable serotyping results which is of paramount importance in the post-PCV-10 era.
Our study revealed that serotyping of S. pneumoniae was dependent on bacterial load, i.e., there was no untypeable S. pneumoniae in very high load (>5 × 106 CFU/ml) and high load categories (between 5 × 105 CFU/ml and 5 × 106 CFU/ml), while the proportion of untypeable results increased in lower load categories. However, the conserved region, i.e., cpsA was present in all the untypeable samples. Therefore, it is likely that these samples were pneumococcal serotypes other than those in our testing repertoire. On the contrary, it is possible that those were truly untypeable, given the 100% success in typing those with low Ct value for lytA, it is more likely that we need more DNA copies for serotyping to work. We intend to resolve these untypeable results through whole-genome sequencing in the future.
Our study has limitations, since this was a field study, blood cultures could not be performed and thus quantitative lytA real-time PCR results could not be compared with a reference test. Furthermore, lytA PCR was not performed in blood samples from healthy children, and therefore we could not determine its diagnostic specificity.
| Conclusion|| |
There is a dire need to evaluate sensitive and rapid assays for a resource-limited setting that can detect S. pneumoniae in blood and will provide a strong foundation for pneumococcal serotyping, and we have described such assay. lytA PCR assay facilitated the diagnosis of IPD in our cohort. Once diagnostic specificity is demonstrated in a healthy cohort of children, this assay can be successfully used for the diagnosis of IPD in children and can be adapted to point-of-care platforms to facilitate rapid field diagnosis.
We gratefully acknowledge the study participants and their families. We would also like to acknowledge the Paediatrics Infectious Diseases Research Laboratory staff, Project field staff and Administration, Department of Paediatrics and Child Health for their dedicated services and assistance.
Financial support and sponsorship
This manuscript is part of a larger study assessing impact of Pneumococcal Conjugate Vaccine (PCV-10) funded by Global Alliance for Vaccines and Immunization (GAVI).
Conflicts of interest
There are no conflicts of interest.
| References|| |
Worldwide burden of disease: Streptococcus pneumoniae and Haemophilus influenza type b in children less than 5 years old Archives of Disease in Childhood 2010;95:973.
Bhutta ZA, Hafeez A, Rizvi A, Ali N, Khan A, Ahmad F, et al
. Reproductive, maternal, newborn, and child health in Pakistan: Challenges and opportunities. Lancet 2013;381:2207-18.
Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, et al
. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007;44 Suppl 2:S27-72.
Morrison KE, Lake D, Crook J, Carlone GM, Ades E, Facklam R, et al
. Confirmation of psaA in all 90 serotypes of Streptococcus pneumoniae
by PCR and potential of this assay for identification and diagnosis. J Clin Microbiol 2000;38:434-7.
Gillespie SH, Ullman C, Smith MD, Emery V. Detection of Streptococcus pneumoniae
in sputum samples by PCR. J Clin Microbiol 1994;32:1308-11.
Strålin K, Törnqvist E, Kaltoft MS, Olcén P, Holmberg H. Etiologic diagnosis of adult bacterial pneumonia by culture and PCR applied to respiratory tract samples. J Clin Microbiol 2006;44:643-5.
Kearns AM, Freeman R, Murphy OM, Seiders PR, Steward M, Wheeler J. Rapid PCR-based detection of Streptococcus pneumoniae
DNA in cerebrospinal fluid. J Clin Microbiol 1999;37:3434.
García A, Rosón B, Pérez JL, Verdaguer R, Dorca J, Carratalà J, et al
. Usefulness of PCR and antigen latex agglutination test with samples obtained by transthoracic needle aspiration for diagnosis of pneumococcal pneumonia. J Clin Microbiol 1999;37:709-14.
Corless CE, Guiver M, Borrow R, Edwards-Jones V, Fox AJ, Kaczmarski EB. Simultaneous detection of Neisseria meningitidis, Haemophilus influenzae
, and Streptococcus pneumoniae
in suspected cases of meningitis and septicemia using real-time PCR. J Clin Microbiol 2001;39:1553-8.
Morozumi M, Nakayama E, Iwata S, Aoki Y, Hasegawa K, Kobayashi R, et al
. Simultaneous detection of pathogens in clinical samples from patients with community-acquired pneumonia by real-time PCR with pathogen-specific molecular beacon probes. J Clin Microbiol 2006;44:1440-6.
McAvin JC, Reilly PA, Roudabush RM, Barnes WJ, Salmen A, Jackson GW, et al
. Sensitive and specific method for rapid identification of Streptococcus pneumoniae
using real-time fluorescence PCR. J Clin Microbiol 2001;39:3446-51.
Abdeldaim G, Herrmann B, Mölling P, Holmberg H, Blomberg J, Olcén P, et al
. Usefulness of real-time PCR for lytA, ply, and Spn9802 on plasma samples for the diagnosis of pneumococcal pneumonia. Clin Microbiol Infect 2010;16:1135-41.
Azzari C, Cortimiglia M, Moriondo M, Canessa C, Lippi F, Ghiori F, et al
. Pneumococcal DNA is not detectable in the blood of healthy carrier children by real-time PCR targeting the lytA gene. J Med Microbiol 2011;60(Pt 6):710-4.
Rello J, Lisboa T, Lujan M, Gallego M, Kee C, Kay I, et al
. Severity of pneumococcal pneumonia associated with genomic bacterial load. Chest 2009;136:832-40.
Verhelst R, Kaijalainen T, De Baere T, Verschraegen G, Claeys G, Van Simaey L, et al
. Comparison of five genotypic techniques for identification of optochin-resistant pneumococcus-like isolates. J Clin Microbiol 2003;41:3521-5.
Whatmore AM, Efstratiou A, Pickerill AP, Broughton K, Woodard G, Sturgeon D, et al
. Genetic relationships between clinical isolates of Streptococcus pneumoniae
, Streptococcus oralis
, and Streptococcus mitis
: Characterization of “Atypical” pneumococci and organisms allied to S. mitis harboring S. pneumoniae virulence factor-encoding genes. Infect Immun 2000;68:1374-82.
Yang S, Lin S, Khalil A, Gaydos C, Nuemberger E, Juan G, et al
. Quantitative PCR assay using sputum samples for rapid diagnosis of pneumococcal pneumonia in adult emergency department patients. J Clin Microbiol 2005;43:3221-6.
Ali A, Husain S, Riaz A, Khawar H. Status of introduction of pneumococcal conjugate vaccine in Pakistan. Pediatric Infect Dis 2016;8:64-6.
World Health Organization Pneumonia Vaccine Trial Investigators Group. Standardization of Interpretation of Chest Radiographs for the Diagnosis of Pneumonia in Children. WHO Document WHO/V&B/01.35. Geneva: WHO; 2001.
Carvalho Mda G, Tondella ML, McCaustland K, Weidlich L, McGee L, Mayer LW, et al
. Evaluation and improvement of real-time PCR assays targeting lytA, ply, and psaA genes for detection of pneumococcal DNA. J Clin Microbiol 2007;45:2460-6.
Emery SL, Erdman DD, Bowen MD, Newton BR, Winchell JM, Meyer RF, et al
. Real-time reverse transcription-polymerase chain reaction assay for SARS-associated coronavirus. Emerg Infect Dis 2004;10:311-6.
Pimenta FC, Roundtree A, Soysal A, Bakir M, du Plessis M, Wolter N, et al
. Sequential triplex real-time PCR assay for detecting 21 pneumococcal capsular serotypes that account for a high global disease burden. J Clin Microbiol 2013;51:647-52.
Pai R, Gertz RE, Beall B. Sequential multiplex PCR approach for determining capsular serotypes of Streptococcus pneumoniae
isolates. J Clin Microbiol 2006;44:124-31.
|This article has been cited by|
||Effectiveness of 10-valent pneumococcal conjugate vaccine against vaccine-type invasive pneumococcal disease in Pakistan
| ||Atif Riaz,Syed Mohiuddin,Sara Husain,Mohammad Tahir Yousafzai,Muhammad Sajid,Furqan Kabir,Najeeb ur Rehman,Waseem Mirza,Basit Salam,Naila Nadeem,Khatidja Pardhan,Khalid Mehmood A. Khan,Syed Jamal Raza,Fehmina Arif,Khalid Iqbal,Hassan Khalid Zuberi,Cynthia G. Whitney,Saad B. Omer,Anita K.M. Zaidi,Asad Ali |
| ||International Journal of Infectious Diseases. 2019; 80: 28 |
|[Pubmed] | [DOI]|